Addex Therapeutics LtdADXNNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank41
Year-over-Year Change
Year-over-year revenue growth rate
Percentile
P41
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -18.28% |
| Q2 2025 | 0.00% |
| Q1 2025 | -100.00% |
| Q4 2024 | -97.20% |
| Q3 2024 | -53.30% |
| Q2 2024 | -50.63% |
| Q1 2024 | 52.15% |
| Q4 2023 | -53.18% |
| Q3 2023 | -48.05% |
| Q2 2023 | 25.95% |
| Q1 2023 | -15.45% |
| Q4 2022 | 44.70% |
| Q3 2022 | 123.29% |
| Q2 2022 | -22.71% |
| Q1 2022 | -40.32% |
| Q4 2021 | -41.72% |
| Q3 2021 | -31.29% |
| Q2 2021 | 17.57% |
| Q1 2021 | -53.63% |
| Q4 2020 | 6578.04% |
| Q3 2020 | -96.83% |
| Q2 2020 | -4.79% |
| Q1 2020 | -13.09% |
| Q4 2019 | 107.06% |
| Q3 2019 | -3.29% |
| Q2 2019 | -25.89% |
| Q1 2019 | 4.98% |
| Q4 2018 | -0.00% |
| Q3 2018 | -75.12% |
| Q2 2018 | 0.00% |
| Q1 2018 | 1865.16% |
| Q4 2017 | 0.00% |
| Q3 2017 | 20.45% |
| Q2 2017 | 0.00% |
| Q1 2017 | 76.81% |
| Q4 2016 | 0.00% |
| Q3 2016 | -54.76% |
| Q2 2016 | 0.00% |
| Q1 2016 | -59.61% |
| Q4 2015 | 0.00% |